1. Home
  2. TRN vs ADPT Comparison

TRN vs ADPT Comparison

Compare TRN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$31.36

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$14.02

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRN
ADPT
Founded
1933
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
TRN
ADPT
Price
$31.36
$14.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
$34.00
$17.78
AVG Volume (30 Days)
507.2K
1.6M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
3.92%
N/A
EPS Growth
85.98
63.89
EPS
3.05
N/A
Revenue
$2,156,900,000.00
$276,976,000.00
Revenue This Year
$1.91
$3.98
Revenue Next Year
$15.61
$22.72
P/E Ratio
$10.34
N/A
Revenue Growth
N/A
54.77
52 Week Low
$22.38
$7.16
52 Week High
$35.62
$20.76

Technical Indicators

Market Signals
Indicator
TRN
ADPT
Relative Strength Index (RSI) 44.47 48.30
Support Level $30.63 $12.22
Resistance Level $35.33 $15.38
Average True Range (ATR) 0.86 0.77
MACD -0.24 0.04
Stochastic Oscillator 17.21 58.78

Price Performance

Historical Comparison
TRN
ADPT

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: